Lipid oxidation products and oxidized low-density lipoproteins impair platelet-derived growth factor receptor activity in smooth muscle cells: Implication in atherosclerosis

Redox Report

Volumn 12, Issue 1-2, 2007, Pages 96-100

  Vindis, Cecile ^a,b   Escargueil Blanc, Isabelle ^a,b   Uchida, Koji ^a,b   Elbaz, Meyer ^a,b   Salvayre, Robert ^a,b   Negre Salvayre, Anne ^a,b  

^a INSERM   (France)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

4 hydroxynonenal; Atherosclerosis; Platelet derived growth factor receptor beta; Smooth muscle cells

Indexed keywords

4 HYDROXYNONENAL; ACROLEIN; APOLIPOPROTEIN E; HYDRALAZINE; OXIDIZED LOW DENSITY LIPOPROTEIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ASCENDING AORTA; ATHEROSCLEROTIC PLAQUE; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; DESENSITIZATION; DRUG MECHANISM; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; LIPID OXIDATION; LONG TERM EXPOSURE; MITOGENESIS; MOUSE; MOUSE STRAIN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEIN TARGETING; RABBIT; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

ACROLEIN; ALDEHYDES; ANIMALS; ATHEROSCLEROSIS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS; PHOSPHORYLATION; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA;

MUS;

EID: 33846813976     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100007X162248     Document Type: Conference Paper

References (18)

1. Heinecke JW. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Curr Opin Lipidol 1997; 8: 268-274.
2. Parthasarathy S, Santanam N. Mechanism of oxidation, antioxidants, and atherosclerosis. Curr Opin Lipidol 1994; 5: 371-375.
3. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996; 20: 707-727.
4. Witztum JL, Steinberg D. The oxidative modification hypothesis, of atherosclerosis: does it hold for humans? Trends Cardiovasc Med 2001; 11: 93-102.
5. Chisolm 3rd GM, Chai Y. Regulation of cell growth by oxidized LDL. Free Radic Biol Med 2000; 28: 1697-1707.
6. Robbesyn F, Salvayre R, Negre-Salvayre A. Dual role of oxidized LDL on the NF-kappaB signaling pathway. Free Radic Res 2004; 38: 541-551.
7. Auge N, Maupas-Schwalm F, Elbaz B et al. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Circulation 2004; 110: 571-578.
8. Suc I, Meilhac O, Lajoie-Mazenc I et al. Activation of EGF receptor by oxidized LDL. FASEB J 1998; 12: 665-671.
9. Escargueil-Blanc I, Salvayre R, Vacaresse N et al. A. mildly oxidized LDL induces activation of PDGF β-receptor pathway. Circulation 2001; 104: 1814-1821.
10. Salvayre R, Auge N, Benoist H, Negre-Salvayre A. Oxidized LDL-induced apoptosis. Biochim Biophys Acta 2002; 1585: 213.
11. Claesson-Welsh L. Platelet-derived growth factor signals. J Biol Chem 1994; 268: 32023-32026.
12. Vindis C, Escargueil-Blanc I, Elbaz M et al. Desensitization of platelet-derived growth factor receptor-beta by oxidized lipids in vascular cells and atherosclerotic lesions: prevention by aldehyde scavengers. Circ Res 2006; 98: 785-792.
13. Aslan M, Ozben T. Oxidants in receptor tyrosine kinase signal transduction pathways. Antioxid Redox Signal 2003; 6: 781-788.
14. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81-128.
15. Vieira O, Escargueil-Blanc I, Jurgens G et al. Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: potential role in oxidized LDL-induced apoptosis. FASEB J 2000; 14: 532-542.
16. Rosenfeld ME, Palinski W, Yla-Herttuala S, Butler S, Witztum JL. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 1990; 10: 336-349.
17. Uchida K, Sasahara M, Morigami N, Hazama F, Kinoshita M. Expression of platelet-derived growth factor B-chain in neointimal smooth muscle cells of balloon injured rabbit femoral arteries. Atherosclerosis 1996; 124: 9-23.
18. Sano H, Sudo T, Yokode M et al. Functional blockade of platelet-derived growth factor receptor-beta but not of receptor-alpha prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice. Circulation 2001; 103: 2955-2960.